MARISOL OCAMPO: Open Payments
NPI 1457859720 · MIAMI BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,407 in 265 payments from 50 companies in 2025. Trend: 2023 $4,960 · 2024 $6,682 · 2025 $7,407
Food & beverage: $6,826Consulting: $540Education: $216
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $691 |
| Janssen Scientific Affairs, LLC | 1 | $540 |
| Novartis Pharmaceuticals Corporation | 27 | $492 |
| Celgene Corporation | 19 | $471 |
| AstraZeneca Pharmaceuticals LP | 11 | $374 |
| PFIZER INC. | 15 | $290 |
| BeOne Medicines USA, Inc. | 8 | $278 |
| Merck Sharp & Dohme LLC | 11 | $248 |
| Daiichi Sankyo Inc. | 9 | $224 |
| Incyte Corporation | 9 | $198 |
Products named: ERLEADA, RYBREVANT, REBLOZYL, KISQALI, TEVIMBRA, DATROWAY, Enhertu, KEYTRUDA.
Industry payments across FL — which companies pay providers there.
